Breast Cancer Clinical Trial Using Endocrine Therapy, Trastuzumab, Lapatinib and Paclitaxel

- The folks at SOLTI Breast Cancer Research Group are studying the effects of Lapatinib; Trastuzumab; Endocrine Therapy; Paclitaxel on Breast Cancer in females ages 18 years and older. This clinical trial is slated to start October 2013 and is expected to end circa December 2015.

0034933436302
Carmen Blasco, PhD
Overall Study Contact Info
StatusName Contact Phone
RecruitingCarmen Blasco, PhDcarmen.blasco@gruposolti.org0034933436302

This study is officially titled, "PAMELA: PAM50 HER2-enriched Phenotype as a Predictor of Early Response to Neoadjuvant Lapatinib Plus Trastuzumab in Stage I to IIIA HER2-positive Breast Cancer."

Locations

Hospital Universitario Arnau de Vilanova de Valencia

Valencia, Spain - Recruiting

Hospital Cl¡nico Universitario de Valencia

Valencia, Spain - Recruiting

Hospital Cl¡nico San Carlos

Madrid, Spain - Recruiting

Hospital Universitario Ram¢n y Cajal

Madrid, Spain - Recruiting

Hospital Universitario Arnau de Vilanova de Lleida

Lleida, Spain - Recruiting

Consorcio Hospitalario Provincial de Castell¢n

Castell¢n, Spain - Recruiting

Vall d'Hebron University Hospital

Barcelona, Spain - Recruiting

Hospital Cl¡nic de Barcelona

Barcelona, Spain - Recruiting

Instituto Dexeus

Barcelona, Spain - Not yet recruiting

Hospital Universitario Sant Joan de Reus

Reus, Tarragona - Recruiting

Hospital Universitario Virgen de la Arrixaca

El Palmar, Murcia - Recruiting

Hospital Universitario de Fuenlabrada

Fuenlabrada, Madrid - Recruiting

Hospital Universitario Son Espases

Palma de Mallorca, Islas Baleares - Recruiting

Hospital Son Ll…tzer

Palma de Mallorca, Islas Baleares - Recruiting

Hospital Cl¡nico Universitario de Santiago de Compostela

Santiago de Compostela, Galicia - Recruiting

Hospital Mutua de Terrassa

Terrassa, Barcelona - Recruiting

Institut Catal… d'Oncologia Hospitalet

Hospitalet de Llobregat, Barcelona - Recruiting

Hospital de Torrevieja

Torrevieja, Alicante - Recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.